Engelhard Corp. - 8K - 03/21/06
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 21, 2006
 
ENGELHARD
CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
1-8142
22-1586002
(State or other jurisdiction of incorporation)
 
(Commission File Number)
(I.R.S. Employer Identification No.)
101 Wood Avenue, Iselin, New Jersey
08830
(Address of principal executive offices)
(Zip Code)

 
Registrant’s telephone number, including area code (732) 205-5000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[X] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 

 


 
Item 8.01 Other Events.
 
On March 21, 2006, the Company issued a press release entitled “Engelhard Says First-Quarter Results To Exceed Analysts’ Expectations.” A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
 

Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits

The following is filed as an exhibit to this report:

99.1   Press release dated March 21, 2006


 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  ENGELHARD
CORPORATION
  
    (Registrant)
   
   
   
Date: March 21, 2006
/s/ Michael A. Sperduto              
 
Name:   Michael A. Sperduto
 
Title:     Vice President and Chief Financial Officer